EZH2 and pancreatic insulinoma: Furthermore, nearly all insulinomas are marked by the overexpression of EZH2. This gain of EZH2 function likely explains the hyperproliferative phenotype and the observed dysregulation of transcriptional programs related to proliferation (Wang et al., 2017).